Navigation Links
iBio Adds New Therapeutic Antibody to Its Pipeline
Date:3/4/2013

NEWARK, Del., March 4, 2013 /PRNewswire/ -- iBio, Inc. (NYSE MKT: IBIO)  announced it is proceeding with development of an antibody candidate as a therapeutic against influenza, including highly pathogenic H5N1 strains resistant to drugs such as oseltamivir (marketed as Tamiflu®). This proprietary antibody, which is based upon iBio's iBioLaunch™ technology,  has demonstrated safety and therapeutic efficacy in highly predictive animal models infected with a variety of influenza types, including H5N1.

(Logo:  http://photos.prnewswire.com/prnh/20120419/NY91086LOGO )

The influenza antibody was discovered by scientists at Fraunhofer USA Center for Molecular  Biotechnology (Fraunhofer) and is a part of Bio's successful antibody research collaboration with Fraunhofer.  Prior to the discovery of this influenza antibody product candidate, the collaboration has produced rituximab and palivizumab biosimilar candidates.

"We are pleased to further expand our antibody product candidate pipeline, particularly with an important proprietary candidate," said Robert Kay , Chairman and CEO of iBio. "This development continues our strategy to grant royalty-bearing licenses of iBioLaunch technology to others for development of their products using our platform, as we recently announced with Caliber Biotherapeutics for their anti-cancer monoclonal antibody candidate, while we continue to bring forward our own product candidates for self-development and eventual partnership with others."

About the iBioLaunch™ Platform

The iBioLaunch platform is a proprietary, transformative technology for development and production of biologics using transient gene expression in unmodified green plants. Advantages over other systems may include: success with prot
'/>"/>

SOURCE iBio, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
2. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
3. Society for Brain Mapping and Therapeutics endorse President Obamas support for Human Brain Mapping research; nominating him for prestigious Pioneer in Healthcare Policy Award
4. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
5. United Therapeutics Announces Additional $420 Million Share Repurchase Program
6. Juventas Therapeutics Hires Biotechnology Veteran Paul Resnick as Vice President of Business Development
7. Convoy Therapeutics Announces the Relaunch of Their Interactive Website
8. Exon skipping to restore gene expression is promising therapeutic strategy for muscular dystrophy
9. Shield Therapeutics Selects OpenClinica Enterprise
10. Regenetek Research Inc. Launches New Intelligent Software for Therapeutic Stem Cell Trials
11. Cell Therapeutics, Inc.s (CTI) Board of Directors Approves Amendment of Shareholder Rights Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... og SHENZHEN , Kina, ... Co., LTD, (BGI Tech), et datterselskab af BGI, ... en ny human whole exome-sekvenseringstjeneste baseret på Complete ... højt anset i branchen for at levere patenterede ... af alle typer varianter, blev købt af BGI ...
(Date:7/22/2014)... , July 22, 2014 Hussey Copper ... MD-Cu 29 antimicrobial copper announces Pullman Regional Hospital,s ... first EPA-registered antimicrobial solid touch surface, at a nominal ... of MRSA, E-coli and other bacteria within 2 hours of ... protecting against bacteria and infectious diseases in its facilities. ...
(Date:7/22/2014)... Quorum Review IRB, the industry leader in central ... called Quick Step™ . The offering went live on ... industry’s need for seamless study start-up with a large volume ... planning 50 or more North American investigator sites, as well ... count of 80 or more. Qualifying studies may also enroll ...
(Date:7/22/2014)... Biofeedback – When a behavioral problem ... medication to best treat it can become a matter ... electroencephalography (EEG) can help predict which medicine will offer ... adverse drug events. , The article “Medication Prediction ... issue of the journal Biofeedback offers evidence that quantitative ...
Breaking Biology Technology:BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3
... this: Web-software services provider Zywave Inc. recently announced ... building being constructed in the Milwaukee County Research Park ... commercial real estate development circles, but the news is more ... story playing out, and an example of how a powerful ...
... Wis. - Claiming that patents and publications used to ... to the isolation and proliferation of human embryonic stem cells, ... response refuting an initial determination by the ... relevancy, made by Carl Gulbrandsen, managing director of WARF, were ...
... - Einstein Wireless , a Wisconsin-based wireless carrier, ... via cell phone about natural disasters, terrorist attacks, and ... its kind in the United States, will use Einstein's ... across most of Wisconsin, and notification equipment from the ...
Cached Biology Technology:Corporate venturing can nurture software success 2Corporate venturing can nurture software success 3Corporate venturing can nurture software success 4Corporate venturing can nurture software success 5Corporate venturing can nurture software success 6WARF questions relevancy of documents used to uphold patent challenge 2WARF questions relevancy of documents used to uphold patent challenge 3
(Date:7/22/2014)... 22, 2014 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its second quarter ended June 30, ... was $6.8 million, an increase of 53% compared to $4.4 ... patent related income in the second quarter of 2014 was ... of 2013. The increase in revenue and operating income was ...
(Date:7/22/2014)... in the Journal of Clinical Investigation ... and dopamine transporter function are linked to ... and attention deficit hyperactivity disorder (ADHD). , ... basis for further exploration of how dopamine ... to brain disorders" said Michelle Sahai, a ...
(Date:7/22/2014)... study that examined the survival rates of 12 ... commercial longline fishing operations found large differences in ... dusky, and scalloped hammerhead being the most,vulnerable. The ... Miami (UM) Rosenstiel School of,Marine and Atmospheric Science ... Policy, provides,new information to consider for future conservation ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7The dopamine transporter 2The dopamine transporter 3New study reveals vulnerability of sharks as collateral damage in commercial fishing 2
... CRUZ, CA--Researchers at the University of California, Santa Cruz, ... from wounds and skin infections, using light to trigger ... developed a photoactive compound that releases nitric oxide when ... biocompatible material that could be applied as a sprayable ...
... percent of their time indoors, but we,re never alone ... of the world,s biomasssome 10 nonillion (1 followed by ... enclosed spaces. So, that,s where the modern microbe hunter ... National Institute of Standards and Technology (NIST) offers guidance ...
... in Action, conference will be held in Copenhagen, ... Europe,s space programme for the GMES Global Monitoring ... European citizens alike. User testimonials of pre-operational ... operational programme and socio-economic assessments will form the ...
Cached Biology News:Light-induced delivery of nitric oxide eradicates drug-resistant bacteria 2Light-induced delivery of nitric oxide eradicates drug-resistant bacteria 3Report details efforts to improve, advance indoor microbial sampling 2
The product contains 2 ml Dynabeads® Epoxy (4.5 μm). Supplied at 4 x 10e8 beads/ml...
... to Endothelin B Receptor Like Protein ... Protein 2 (ETBR-LP-2) has been reported ... isolated from human brain and colon ... peptide (unfortunately, the amino acid sequence ...
... recognized by A300-183A maps to ... of human quaking homolog according ... The epitope is not ... 3, 4, 6, 7 or ...
Flotillin-2 (ESA) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 29, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Biology Products: